BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3470098)

  • 1. Not-for-profit HMOs.
    Burrell CE
    Bull N Y Acad Med; 1987; 63(1):61-7. PubMed ID: 3470098
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospitals.
    Kinzer D
    Bull N Y Acad Med; 1987; 63(1):79-86. PubMed ID: 3470102
    [No Abstract]   [Full Text] [Related]  

  • 3. For-profit HMOs and joint ventures.
    Wasserman FW
    Bull N Y Acad Med; 1987; 63(1):49-60. PubMed ID: 3470097
    [No Abstract]   [Full Text] [Related]  

  • 4. HMOS stimulate competition, FTC concludes.
    Greenberg W
    Hosp Prog; 1977 Oct; 58(10):10-1. PubMed ID: 903113
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Blues' costs offers fascinating insights.
    Capitation Rates Data; 2000 May; 5(5):49-51. PubMed ID: 11066969
    [No Abstract]   [Full Text] [Related]  

  • 7. Blues plan more HMO involvement.
    Employee Benefit Plan Rev; 1978 Sep; 33(3):34. PubMed ID: 10277895
    [No Abstract]   [Full Text] [Related]  

  • 8. The great health care rip-off.
    Claiborne R
    Saturday Rev; 1978 Jan; 5(7):10-13, 16, 50. PubMed ID: 10304535
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the hospital cost experience of three competing HMOs.
    Gavett JW; Smith DB
    Inquiry; 1978 Dec; 15(4):327-35. PubMed ID: 152291
    [No Abstract]   [Full Text] [Related]  

  • 10. A note on the comparison of the hospital cost experience of three competing HMOs.
    Sorensen AA; Wersinger RP; Roghmann KJ; Gavett JW
    Inquiry; 1979; 16(2):167-71. PubMed ID: 156159
    [No Abstract]   [Full Text] [Related]  

  • 11. HMOs dump more Medicare patients.
    Bloice C
    Revolution (Oakl); 2003; 4(5):9. PubMed ID: 14631718
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of ownership conversions on HMO performance.
    Town R; Feldman R; Wholey D
    Int J Health Care Finance Econ; 2004 Dec; 4(4):327-42. PubMed ID: 15467408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blues increase coverage, cut utilization in areas where HMOs are strong, study shows.
    Employee Benefit Plan Rev; 1977 Oct; 32(4):16-7. PubMed ID: 10304853
    [No Abstract]   [Full Text] [Related]  

  • 14. Blues' reimbursement, managed competition, and House Bill 630.
    Giordano JA
    Pa Med; 1995 Nov; 98(11):10. PubMed ID: 7501408
    [No Abstract]   [Full Text] [Related]  

  • 15. BC/BS activity in alternate delivery systems.
    Employee Benefit Plan Rev; 1982 Jul; 37(1):16. PubMed ID: 10259393
    [No Abstract]   [Full Text] [Related]  

  • 16. The new health care: the Blue Cross and Blue Shield organization's response to change.
    Kaplan SM
    J Med Pract Manage; 1985 Oct; 1(2):110-3. PubMed ID: 10281822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Blues rise again. Amid industry turmoil, trademark seen as refuge.
    Benko LB
    Mod Healthc; 2002 Sep; 32(36):14-5. PubMed ID: 12298320
    [No Abstract]   [Full Text] [Related]  

  • 18. The dynamics of power in the marketplace.
    Cochrane JD
    Integr Healthc Rep; 1998 Jul; ():1-5. PubMed ID: 10182826
    [No Abstract]   [Full Text] [Related]  

  • 19. Reforming health care delivery: the Massachusetts Blues' role.
    Getson J
    Bus Health; 1987 Feb; 4(4):30-4. PubMed ID: 10280664
    [No Abstract]   [Full Text] [Related]  

  • 20. Blue Cross warns the administration: move cautiously on health care changes. Interview by Linda E. Demkovich.
    McNerney WJ
    Natl J (Wash); 1981 May; 13(18):789-90. PubMed ID: 10250893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.